High-throughput screening automation and BLI technology implementation at Sanofi for engineering next-generation multi-specific antibody therapeuticsSpeakers: Anja Wille, Sanofi, Matilde Marques, SelectScienceSpeakers: Anja Wille, Sanofi · Matilde Marques, SelectScienceSpeakers: Anja Wille, SanofiMatilde Marques, SelectScience · · +1 more · +2 moreWatch on-demand